Cristin L. Rothfuss - EVP, General Counsel at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel
Issuer Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cristin L. Rothfuss since 09 Mar 2025

Holdings reported by Cristin L. Rothfuss for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 139,348 $2,257,437 $16.20 02 Mar 2026 Direct
Stock Options (right to buy) 16,644 10 Mar 2025 Direct Common Stock

Transactions reported by Cristin L. Rothfuss for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.